Valeria Merz

17PUBLICATIONS
47CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 11, 2024
Complete pathological response to pembrolizumab in pretreated pancreatic acinar cell carcinoma.

Valeria Merz, Francesca Maines, Stefano Marcucci

|Apr 08, 2024
Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bear.

Davide Melisi, Simona Casalino, Silvia Pietrobono

|Sep 28, 2023
YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer.

Maria Bencivenga, Lorena Torroni, Mariagiulia Dal Cero

|Sep 22, 2023
Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma.

Silvia Pietrobono, Fabio Sabbadini, Monica Bertolini

|Jun 06, 2023
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma.

Letizia Procaccio, Valeria Merz, Morena Fasano

|Mar 29, 2023
Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab.

Camilla Zecchetto, Alberto Quinzii, Simona Casalino

Pageof 3

Frequent Collaborators

11 joint publications

Davide Melisi

4 joint publications

Simona Casalino

4 joint publications

Camilla Zecchetto

3 joint publications

Alberto Quinzii